JPMorgan to price 9% reverse exchangeables linked to Pfizer

By E. Janene Geiss

Philadelphia, March 12 - JPMorgan Chase & Co. plans to price 9% annualized reverse exchangeable notes due March 31, 2009 linked to the common stock of Pfizer Inc., according to an FWP filing with the Securities and Exchange Commission.

Interest will be payable monthly.

Investors will receive par unless Pfizer stock falls below 80% of the initial share price during the life of the notes and finishes below the initial share price, in which case the payout will be a number of Pfizer shares equal to $1,000 divided by the initial share price.

The notes are expected to price on March 26 and settle on March 31.

J.P. Morgan Securities Inc. will be the agent.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.